Amarin Corporation, a clinical-stage biopharmaceutical company, has appointed John Thero as chief financial officer (CFO). In this role, he will have broad responsibility for financial and administrative matters of the company and be actively involved in corporate development and other strategic and operational matters. He will report directly to Dr. Declan Doogan, Amarin’s interim chief executive officer (CEO).
Thero has more than 20 years of senior financial and operational management experience, including over 15 years supporting the growth of life science companies. Previously, he was CFO at ViaCell, where he helped guide the company to its successful sale, and Abiomed, during its transition from a development-stage company into a commercial entity. Thero began his professional career at Arthur Andersen, during which time he became a certified public accountant (CPA).
The annual BNP Paribas Cash Management University kicked off on Thursday morning with treasury professionals congregating in Paris from across Europe.
APIs may be a solution to MT940 challenges, says Karen Fagan, treasury operation manager, for British television company, ITV.
Kicking off the first day of the Singapore Fintech Festival, issues with cryptocurrencies were addressed by MIT media labs director, Joi Ito, and panels of technology leaders discussed how they’re using data analytics.
Sibos 2017 day two highlights: Brexit and banking, and why ‘data is the new oil’ in financial services
How nation first politics can impact global financial organisations It’s clear that data and regulation are the two key topics that are ... read more